Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism GPR40 agonists(Free fatty acid receptor 1 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H19F3N2O4S |
InChIKeyBMLGZNVPWRUVNM-IBGZPJMESA-N |
CAS Registry1011531-27-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Preclinical | United States | 20 Feb 2014 |





